VVM
Versant Venture Management Portfolio holdings
AUM
$82.1M
This Quarter Return
-12.8%
1 Year Return
-26.22%
3 Year Return
+73.87%
5 Year Return
-1.11%
10 Year Return
+1,578.11%
AUM
$187M
AUM Growth
+$187M
(-23%)
Cap. Flow
-$21.3M
Cap. Flow
% of AUM
-11.4%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
12
New
1
Increased
–
Reduced
2
Closed
2
Top Buys
| 1 |
UTRS
Minerva Surgical, Inc. Common Stock
UTRS
|
$8.6M |
Top Sells
| 1 |
Crinetics Pharmaceuticals
CRNX
|
$11.7M |
| 2 |
Aprea Therapeutics
APRE
|
$6.44M |
| 3 |
FLXN
Flexion Therapeutics, Inc.
FLXN
|
$6.1M |
| 4 |
GRTS
Gritstone bio, Inc. Common Stock
GRTS
|
$5.72M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
GRTS
1
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
| $45.8M | 24.49% | 3,561,150 -444,744 | -11% | -$5.72M |
|
2
CRISPR Therapeutics
CRSP
$4.71B
| $37.8M | 20.21% | 498,558 | – | – |
|
3
Passage Bio
PASG
$22.7M
| $31.5M | 16.84% | 4,959,769 | – | – |
|
4
Aligos Therapeutics
ALGS
$73.3M
| $27.5M | 14.73% | 2,320,381 | – | – |
|
5
Akero Therapeutics
AKRO
$3.74B
| $13.1M | 6.99% | 617,727 | – | – |
|
|
6
Crinetics Pharmaceuticals
CRNX
$2.92B
| $11.7M | 6.24% | 410,360 -410,360 | -50% | -$11.7M |
|
7
Adverum Biotechnologies
ADVM
$64.6M
| $8.92M | 4.77% | 5,068,233 | – | – |
|
|
UTRS
8
DELISTED
Minerva Surgical, Inc. Common Stock
UTRS
| $8.6M | 4.6% | +1,673,700 | New | +$8.6M |
|
|
CBAY
9
DELISTED
Cymabay Therapeutics
CBAY
| $1.84M | 0.98% | 543,753 | – | – |
|
|
CLVS
10
DELISTED
Clovis Oncology, Inc.
CLVS
| $276K | 0.15% | 101,855 | – | – |
|
|
11
Aprea Therapeutics
APRE
$9.09M
| – | – | -1,259,662 | Closed | -$6.44M |
|
|
FLXN
12
DELISTED
Flexion Therapeutics, Inc.
FLXN
| – | – | -1,000,000 | Closed | -$6.1M |
|